Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13252818Application Date: 2011-10-04
-
Publication No.: US08933110B2Publication Date: 2015-01-13
- Inventor: Yao-Ling Qiu , Ce Wang , Xiaowen Peng , Lu Ying , Hui Cao , Yat Sun Or
- Applicant: Yao-Ling Qiu , Ce Wang , Xiaowen Peng , Lu Ying , Hui Cao , Yat Sun Or
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Roy P. Issac; Carolyn S. Elmore, Esq.
- Main IPC: C07D207/16
- IPC: C07D207/16 ; C07D209/44 ; A61K38/00 ; A61P31/14 ; A61K31/415 ; A61K31/4188 ; A61K31/4196 ; A61K31/424 ; A61K31/427 ; A61K31/4439 ; A61K31/454 ; A61K31/5377 ; A61K45/06 ; C07D471/22 ; C07D487/18 ; C07D487/22 ; C07D498/18 ; C07D498/22 ; C07D513/18
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: Q-G-A-L-B—W (I), which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20120076755A1 Hepatitis C Virus Inhibitors Public/Granted day:2012-03-29
Information query
